Saham Group completes its withdrawal from healthcare in Morocco with the sale of Saham Pharma
Following the sale of several clinics in Morocco, the Saham Group conglomerate, owned by Moroccan tycoon Moulay Hafid Elalamy, is in the process of finalising its exit from the health sector after accepting the joint offer from the investment fund SPE Capital and the subsidiary of the French Development Agency (AFD), Proparco, for the purchase of Saham Pharma.
14/01/2020 at 16h16, by Africa Business+
The company which specialises in the production of
Recommended articles
Advisory
10/11/2023 at 16h29, by Africa Business+
Morocco: Rochdi Talib entrusts LMS-CSA with Akdital reputation assessment
One year after its IPO on the Casablanca stock exchange, Morocco’s leading private healthcare provider...
Health
26/05/2023 at 15h57, by Africa Business+
Moroccan start-up Datapathology raises almost €1m in seed funding
The medical start-up had already secured over €180,000 18 months ago.
Health
29/06/2021 at 13h47, by Africa Business+
South African conglomerate Ascendis Health sells 49% stake in Farmalider
The transaction—worth ZAR84 million (€4.98 million)—will allow Ascendis Health to reduce its debt. The...
Bank & Insurance
05/05/2021 at 22h21, by Africa Business+
Said Alj to step down from the presidency of Saham Assurance Maroc after selling his shares to Sanlam
By cashing in €116 million from the South African financial group, the Moroccan tycoon has access to...
Advisory
13/04/2021 at 19h28, by Africa Business+
Health: American IQVIA surveys French-speaking West African markets
The USA group specialising in consulting in the health sector is setting up in Abidjan to study the...
Private Equity
05/11/2020 at 22h39, by Africa Business+
Tarek Mounib, the potential buyer of Ridha Charfeddine’s Unimed assets
Tunisian businessman Ridha Charfeddine is planning to sell his pharmaceutical company to a new player...